Award

Programmed translation arrest controlled by nascent peptides and antibiotics

Description: PUBLIC HEALTH RELEVANCE: PROJECT NARRATIVE One of the major challenges of modern medicine is combating the spread of resistance to antibiotics. Many bacterial pathogens activate expression of the resistance genes in response to the presence of antibiotics. Understanding the molecular mechanisms of inducible resistance will, among other applications, pave the way for novel strategies to develop superior drugs capable of curbing bacterial infections. __SpecificAimsTextDelimiter__ Nascent peptide-controlled translation arrest regulates expression of several important bacterial and eukaryotic genes. This mechanism reflects the fundamental property of the ribosome to modulate its functions according to the structure of the nascent peptide in the exit tunnel. Ribosome stalling often also requires the presence of specific small molecules and thus reveals the ribosome as a sensor of the cell's physiological state. However, the principles of recognition of the nascent peptide and small molecular weight cofactors of stalling remain obscure. The most medically relevant genes controlled by nascent peptide-dependent ribosome stalling are the inducible genes of resistance to macrolide antibiotics. One of the prevalent types of regulatory cistrons at which ribosome stalling takes place encode nascent peptides characterized by the presence of a conserved Arg-Leu-Arg sequence (the 'RLR' peptides). Our preliminary investigation showed that extremely short nascent peptides of this class composed of only three (or possibly four) amino acids can efficiently direct macrolide- dependent translation arrest. The availability of such a short stalling peptide and the knowledge of the precise binding site of the antibiotic molecule that serves as a stalling cofactor offer exceptional opportunities for unraveling the molecular mechanisms of programmed translation arrest. In this proposal, we will investigate the mechanism of the nascent peptide- and antibiotic- dependent ribosome stalling controlled by the minimalist peptide and antibiotic. At the fundamental level, our anticipated results should unravel the basic principles of a potentially broadly used mechanism of translation regulation and ribosomal response to the nascent peptide and small molecules. In practical terms, our study will provide important information about the control of expression of clinically relevant antibiotic resistance genes and may provide new approaches for developing superior antibiotics capable of avoiding the action of inducible resistance genes. In our proposed project we will pursue the following specific aims: Specific aim 1. Elucidate features of the nascent peptide and aminoacyl-tRNA essential for antibiotic- dependent programmed translation arrest. Specific aim 2. Unravel the role of the antibiotic cofactor in ribosome stalling with the 'RLR' nascent peptides Specific aim 3. Identify the ribosomal sensors of the stalling signal and elucidate the structure of the arrested ribosome.
Funding type: research
Funder scheme: R01
Start date: 2012-09-30
End date: 2017-08-31
Institutions: University of Illinois Chicago, UNIVERSITY OF ILLINOIS AT CHICAGO
Funded outputs count: 6
Funder award ID: R01GM104370
OpenAlex ID: G8455463535
2014 · Yury S. Polikanov, Ilya A. Osterman, et al. · Molecular Cell · 98
2014 · Stefan Arenz, Sezen Meydan, et al. · Molecular Cell · 117
2014 · Shanmugapriya Sothiselvam, Bo Liu, et al. · Proceedings of the National Academy of Sciences · 127
2014 · Nora Vázquez-Laslop, Alexander S. Mankin · Cell · 9
2014 · Stefan Arenz, Haripriya Ramu, et al. · Nature Communications · 153